Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

CapitalMonk Sep. 3 at 9:29 PM

$PFE Price: $28.81 (-0.72%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.81% RSI: 71.2 | Momentum: Moderate Volume: -29.1% vs avg Volatility: 1.46% Support: $26.05 | Resistance: $29.21 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

walfofwallstreet Sep. 3 at 9:27 PM

$MDCX can be huge 💎👀👀🐺 You can’t go wrong with $1 billion deal with Pfizer $PFE New cancer drug The deal finalised ✅

0 · Reply

walfofwallstreet Sep. 3 at 8:57 PM

$MDCX finalized $1 billion deal with Pfizer $PFE 🫵 $MDCX Medicus get started on its new cancer drug 💎 This is huge 💎 The deal worth $1 billion 🤯

0 · Reply

Agent8 Sep. 3 at 8:44 PM

$PFE @walfofwallstreet “Medicus Pharma is paying the drugmaker $12 million upfront for rights to PF-08046031, which targets melanotransferrin, or CD228, a protein highly expressed in melanoma and several other solid tumors. Medicus also owes Pfizer another $15 million on Sept. 2, 2027, the first anniversary of the deal, according to a filing with the Securities and Exchange Commission. Should the ADC make it to market, Pfizer would be eligible for royalties and could also earn more than $1 billion in development, regulatory and sales milestone payments. The Big Pharma also pitched in $2 million to help Medicus get started on its new cancer prospect.’ https://www.fiercebiotech.com/biotech/pfizer-offloads-scrapped-seagen-adc-medicus-pharma-1b-deal LT

0 · Reply

walfofwallstreet Sep. 3 at 8:38 PM

$MDCX huge $1 billion dollar licensing deal finalized with Pfizer $PFE 🔥🔥 $MDCX huge upcoming 💎🫵

0 · Reply

NEWBIGTECH Sep. 3 at 8:27 PM

$PFE The Fauci diaries strongly suggest that an entire class of scientists, pundits, and officials were united in a grand scheme to delay seroprevalence for as long as possible. https://brownstone.org/articles/pfizer-and-the-cia-privately-cited-high-population-immunity-in-may-2020-unclassified-document-reveals/

0 · Reply

DipBuyInvester Sep. 3 at 8:19 PM

$MDCX will be back on fire..$PFE news!!

1 · Reply

walfofwallstreet Sep. 3 at 8:05 PM

$MDCX huge $1 billion dollar licensing deal with $PFE $MDCX huge upcoming 💎🫵

0 · Reply

walfofwallstreet Sep. 3 at 7:57 PM

$MDCX huge $1 billion dollar licensing deal with $PFE 💎🫵

0 · Reply

walfofwallstreet Sep. 3 at 7:49 PM

$MDCX 💎🚨💰👀👀👀👀🐺 Massive $1 billion licensing deal 🗞️💎🔥 $MDCX Finalized $1 billion licensing deal with Pfizer $PFE for antibody drug conjugate 💎 This is a massive deal💎 $MDCX should be up huge 🫵 huge upcoming 💎👇👇👇👇💎

1 · Reply

Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer

PCVX TEVA

Sep 2, 2026, 9:00 AM EDT - 1 day ago

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

XRAY

Aug 31, 2026, 1:20 PM EDT - 3 days ago

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

LLY NVO TAK

Aug 31, 2026, 12:09 PM EDT - 3 days ago

Trump administration to announce drug pricing deals

AMGN LLY TAK

Aug 27, 2026, 5:48 PM EDT - 6 days ago

US FDA approves updated COVID vaccines for 2026-27 season

MRNA NVAX SNY BNTX

2026-08-27T20:35:15.000Z - 7 days ago

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

BNTX

Aug 27, 2026, 4:30 PM EDT - 7 days ago

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

BNTX

Aug 26, 2026, 12:48 PM EDT - 8 days ago

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

AMGN LLY

2026-08-24T12:18:00.000Z - 10 days ago

Pfizer Stock (PFE) Is a Buy despite Declining Revenue

2026-08-19T14:35:12.000Z - 15 days ago

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

BNTX MRK MRNA

2026-08-16T13:55:21.000Z - 18 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

2026-08-14T18:45:04.000Z - 20 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Aug 14, 2026, 1:45 PM EDT - 20 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 11:46 AM EDT - 20 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:11 AM EDT - 20 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

2026-08-14T13:47:35.000Z - 20 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Aug 14, 2026, 1:00 AM EDT - 20 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 7:24 AM EDT - 4 weeks ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 4 weeks ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 4 weeks ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Aug 4, 2026, 6:52 AM EDT - 4 weeks ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:45 AM EDT - 4 weeks ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Jul 30, 2026, 7:48 AM EDT - 5 weeks ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 5 weeks ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 6 weeks ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 6 weeks ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 6 weeks ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 7 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 7 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 1 month ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 2 months ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 2 months ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 2 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 3 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 3 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 3 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 3 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 3 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

CapitalMonk Sep. 3 at 9:29 PM

0 · Reply

walfofwallstreet Sep. 3 at 9:27 PM

$MDCX can be huge 💎👀👀🐺 You can’t go wrong with $1 billion deal with Pfizer $PFE New cancer drug The deal finalised ✅

0 · Reply

walfofwallstreet Sep. 3 at 8:57 PM

$MDCX finalized $1 billion deal with Pfizer $PFE 🫵 $MDCX Medicus get started on its new cancer drug 💎 This is huge 💎 The deal worth $1 billion 🤯

0 · Reply

Agent8 Sep. 3 at 8:44 PM

0 · Reply

walfofwallstreet Sep. 3 at 8:38 PM

$MDCX huge $1 billion dollar licensing deal finalized with Pfizer $PFE 🔥🔥 $MDCX huge upcoming 💎🫵

0 · Reply

NEWBIGTECH Sep. 3 at 8:27 PM

0 · Reply

DipBuyInvester Sep. 3 at 8:19 PM

$MDCX will be back on fire..$PFE news!!

1 · Reply

walfofwallstreet Sep. 3 at 8:05 PM

$MDCX huge $1 billion dollar licensing deal with $PFE $MDCX huge upcoming 💎🫵

0 · Reply

walfofwallstreet Sep. 3 at 7:57 PM

$MDCX huge $1 billion dollar licensing deal with $PFE 💎🫵

0 · Reply

walfofwallstreet Sep. 3 at 7:49 PM

1 · Reply

RookyMoves Sep. 3 at 7:08 PM

$PFE Dec 28 Leaps feel too cheap here. May add if we see one more weekly test around 27.

0 · Reply

TheWinningStock Sep. 3 at 6:12 PM

$PFE .....🤑🚀

0 · Reply

SellasgpsCurativeBAT11 Sep. 3 at 5:49 PM

$JNJ $PFE $SLS Part 2. Sellas CFO’s John Burns twin Brother Michael Burns was hired earlier in the year by Pfizer and I don’t think it’s a coincidence. 👇 ✌️🙏❤️‍🩹

0 · Reply

SellasgpsCurativeBAT11 Sep. 3 at 5:43 PM

$SLS $JNJ $PFE Pfizer is my # 2 Suitor on the table right now. ✌️🙏❤️‍🩹

0 · Reply

NEWBIGTECH Sep. 3 at 4:41 PM

$PFE https://brownstone.org/articles/pfizer-and-the-cia-privately-cited-high-population-immunity-in-may-2020-unclassified-document-reveals/

0 · Reply

Stocktwits52wHighs Sep. 3 at 4:01 PM

$PFE printed a new 52-week high today

0 · Reply

Scoty_D Sep. 3 at 2:44 PM

$PFE Find that vwap, and giddy on up!

0 · Reply

SignalsAlpha Sep. 3 at 2:40 PM

$PFE SignalsAlpha snapshot: Signal: Bullish Time frame: 4h Strength: Strong Confidence: 93% Context: The current SignalsAlpha signal is aligned with a bullish market state on the 4hr timeframe. Watching: Whether follow-through stays aligned or fades on later SignalsAlpha updates.

0 · Reply

MrPeanutEsquire Sep. 3 at 2:28 PM

$PFE At least its still easy to predict

0 · Reply

Sam1381 Sep. 3 at 2:26 PM

$PFE Failed to remain above $29 as expected. < $20 soooooooon.

1 · Reply

zustrelaax Sep. 3 at 2:24 PM

$PFE looks like a shake , one news will move it to 35 , could be anytime

0 · Reply

1hawk Sep. 3 at 2:23 PM

$PFE do i average up or wait and see?

2 · Reply

Market Cap	162.73B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	9.33
Forward PE	9.56
Profit Margin	12.42%
Debt to Equity Ratio	0.74

Volume	25,235,396
Avg Vol	41,664,922
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	95%
Beta	0.34
Analysts	Sell
Price Target	$28.60